BioCentury | Feb 9, 2004
Emerging Company Profile

Corporate Profile

...Technology Lausanne Number of employees: 8 Funds raised: CHF3 million ($2.3 million) Investors: VI Partners; BV Group...
BioCentury | Feb 3, 1997
Clinical News

Sequus preclinical data

...response rate compared with 25 percent in the ABV group and 23 percent in the BV group...
Items per page:
1 - 2 of 2
BioCentury | Feb 9, 2004
Emerging Company Profile

Corporate Profile

...Technology Lausanne Number of employees: 8 Funds raised: CHF3 million ($2.3 million) Investors: VI Partners; BV Group...
BioCentury | Feb 3, 1997
Clinical News

Sequus preclinical data

...response rate compared with 25 percent in the ABV group and 23 percent in the BV group...
Items per page:
1 - 2 of 2